0001077183-22-000009.txt : 20220208 0001077183-22-000009.hdr.sgml : 20220208 20220208191244 ACCESSION NUMBER: 0001077183-22-000009 CONFORMED SUBMISSION TYPE: 5 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20211231 FILED AS OF DATE: 20220208 DATE AS OF CHANGE: 20220208 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Gilbert Halley E CENTRAL INDEX KEY: 0001601360 FILING VALUES: FORM TYPE: 5 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35756 FILM NUMBER: 22603340 MAIL ADDRESS: STREET 1: C/O IRONWOOD PHARMACEUTICALS, INC. STREET 2: 100 SUMMER STREET, SUITE 2300 CITY: BOSTON STATE: MA ZIP: 02110 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NEOGENOMICS INC CENTRAL INDEX KEY: 0001077183 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 742897368 STATE OF INCORPORATION: NV FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 9490 NEOGENOMICS WAY CITY: FORT MYERS STATE: FL ZIP: 33912 BUSINESS PHONE: 2397680600 MAIL ADDRESS: STREET 1: 9490 NEOGENOMICS WAY CITY: FORT MYERS STATE: FL ZIP: 33912 FORMER COMPANY: FORMER CONFORMED NAME: AMERICAN COMMUNICATIONS ENTERPRISES INC DATE OF NAME CHANGE: 19990120 5 1 wf-form5_164436554542544.xml FORM 5 X0306 5 2021-12-31 0 0 0 0001077183 NEOGENOMICS INC NEO 0001601360 Gilbert Halley E 9490 NEOGENOMICS WAY FORT MYERS FL 33912 0 1 0 0 Chief Legal Officer Common Stock 2021-12-31 5 L 0 177 31.30 A 105263 D Stock Option (Right to Buy) 42.21 2028-08-17 Common Stock 63331.0 63331 D These shares were acquired pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) during the year ended December 31, 2021. The shares were acquired in transactions exempt from Section 16b-3. On August 17, 2021, Ms. Gilbert was granted 63,331 stock options. These options vest ratably over the first four anniversary dates of the grant date. /s/ Halley E. Gilbert 2022-02-08